ஜேசன் டீட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஜேசன் டீட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஜேசன் டீட் Today - Breaking & Trending Today
Reddit investors drive up silver for the second day Bloomberg Silver jumped for a second day on Friday as the market remains on high alert after a call by Reddit Inc posters to create a short squeeze sparked sharp moves on Thursday. Silver for March delivery rose US$0.99 to US$26.91 On Thursday, silver miners’ shares spiked and the largest silver exchange-traded fund, iShares Silver Trust, saw a frenzy of options buying after the market emerged as a target on the Reddit forum r/wallstreetbets. The WallStreetBets forum on the Reddit Inc Web site is displayed on a laptop and the Reddit logo is displayed on a smartphone in Hastings-On-Hudson, New York, on Friday. ....
Analysts from Barclays, Raymond James, and Baird all downgraded their ratings for Arcturus on Tuesday. Arcturus released clinical and preclinical data for its COVID-19 vaccine candidate, ARCT-021, on Monday while also announcing that the Singapore Health Sciences Authority approved the vaccine for Phase 2 clinical studies. Barclays analyst Gena Wang wrote that the interim data of the vaccine candidate was disappointing, per Seeking Alpha. Arcturus Therapeutics fell as much as 53% to $40 on Tuesday, extending its losses for a second straight day after Wall Street was disappointed with the medical company s COVID-19 vaccine updates. Arcturus released clinical and preclinical data for its COVID-19 vaccine candidate, ARCT-021 on Monday while also announcing that the Singapore Health Sciences Authority approved the vaccine for Phase 2 clinical studies. ....
Goldman s answer: No Advertisement Despite the severity of the health crisis, state and local authorities have only tightened restrictions on economic activity modestly on average. Over the next month or two, early vaccination efforts targeting the most vulnerable segments of the population should produce a decline in hospitalizations, the key variable that has most often forced reluctant authorities to impose new restrictions. If so, restrictions are unlikely to get much tighter. We have raised our Q1 GDP growth forecast to +5% on a quarterly annualized basis and see a negative print as unlikely, Goldman said. 2. Will the virus threat fade enough for dense cities and high-rise service industries to recover? ....
» AstraZeneca s stock jumps after the UK authorizes emergency use of its vaccine, which it created with Oxford University AstraZeneca s stock jumps after the UK authorizes emergency use of its vaccine, which it created with Oxford University Shalini NagarajanDec 30, 2020, 18:17 IST Dado Ruvic/Reuters UK authorized the Oxford University. It is the second vaccine authorized for emergency use in the UK, after Pfizer and BioNTech s. AstraZeneca s vaccine is easy to store and requires standard refrigeration. Other COVID-19 shots need cold storage. One chief market strategist said these less cumbersome logistical needs could help the vaccine end further UK restrictions. The pharma group was among the FTSE 100 s leaders as its shares jumped 0.7% in early European trading. Its shares were up about 3.3% at the start of trade. ....
According to DataTrek co-founders Nicholas Colas and Jessica Rabe, the curse refers to the stock markets general inability to post three consecutive years of returns greater than 10%. Since 1928, the market has only posted three years or more of consecutive 10% or greater returns five times: during World War 2, the Korean War, the start of the Vietnam War, the late 1990s bull market, and the aftermath of the financial crisis in 2012, DataTrek said. Advertisement Following a 31% gain in 2019 and a likely 15% gain in 2020, the S&P 500 will be staring down the curse in 2021. But there are 3 potential upside surprises that could propel US stocks higher and help break the curse, according to the note. ....